Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Expands By 6.1%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 31,200 shares, an increase of 6.1% from the December 31st total of 29,400 shares. Based on an average trading volume of 42,900 shares, the short-interest ratio is presently 0.7 days. Approximately 3.8% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Separately, Maxim Group reissued a “buy” rating and issued a $12.00 price objective on shares of Heart Test Laboratories in a research report on Wednesday, December 18th.

Heart Test Laboratories Price Performance

Shares of NASDAQ:HSCS opened at $3.24 on Monday. The company has a market cap of $3.17 million, a P/E ratio of -0.41 and a beta of 2.90. The business has a fifty day simple moving average of $3.55 and a 200-day simple moving average of $3.46. Heart Test Laboratories has a 52 week low of $2.36 and a 52 week high of $18.50. The company has a quick ratio of 1.52, a current ratio of 1.72 and a debt-to-equity ratio of 0.01.

Heart Test Laboratories (NASDAQ:HSCS) last posted its quarterly earnings results on Monday, December 16th. The company reported ($2.27) EPS for the quarter, beating the consensus estimate of ($2.30) by $0.03. During the same period in the previous year, the firm posted ($15.92) earnings per share. Equities research analysts forecast that Heart Test Laboratories will post -9.82 EPS for the current year.

Heart Test Laboratories Company Profile

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.